Evidence map›Paper›PMID 42267316›Full record

ReviewJAC-antimicrobial resistance2026

Carbapenemases: epidemiology, detection and management in a changing global landscape.

Nenad Macesic, Patrick N A Harris, Yin Mo, Angela Gomez-Simmonds

Abstract readReview
In one paragraph

Review in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nenad MacesicDepartment of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Level 1, Alfred Lane House, 55 Commercial Rd, Melbourne, VIC 3004, Australia.ORCID https://orcid.org/0000-0002-7905-628X
Patrick N A HarrisThe University of Queensland, Faculty of Health, Medicine and Behavioural Sciences, UQ Centre for Clinical Research, Building 71/918, Herston, Australia.ORCID https://orcid.org/0000-0002-2895-0345
Yin MoADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.ORCID https://orcid.org/0000-0002-0216-9550
Angela Gomez-SimmondsDivision of Infectious Diseases, Department of Internal Medicine, UC Davis Health, Sacramento, CA, USA.ORCID https://orcid.org/0000-0001-5078-7137

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenemase-producing Gram-negative bacteria are a growing threat to last-line beta-lactam (BL) therapy and are now established across Enterobacterales,

Identifiers

PMID42267316
PMCPMC13245409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.